Published on
February 3, 2022
- 14:15 GMT
bioRemedies MD Announces New Adjunct Therapies for Immunity and Inflammation
Maryland University School of Integrated Health Report Validates the Pharmacology and Benefits of bioRemedies MD's Proprietary CBD Products BALTIMORE, MARYLAND, UNITED STATES, February 3, 2022 /EINPresswire.com/ -- Today, bioRemedies MD announced …
Distribution channels:
Banking, Finance & Investment Industry, Companies
...
